Insufficient scRNA-seq data for expression of NOXO1 at single-cell level.
Insufficient scRNA-seq data for expression of NOXO1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 48% | 0.76 | 108 / 226 | 0% | 0 | 0 / 406 |
brain | 45% | 0.83 | 1188 / 2642 | 0% | 0 | 0 / 705 |
intestine | 32% | 0.55 | 309 / 966 | 0% | 0 | 0 / 527 |
kidney | 31% | 0.38 | 28 / 89 | 0% | 0 | 0 / 901 |
prostate | 25% | 0.33 | 61 / 245 | 0% | 0 | 0 / 502 |
ovary | 24% | 0.27 | 43 / 180 | 0% | 0 | 0 / 430 |
spleen | 21% | 0.27 | 50 / 241 | 0% | 0 | 0 / 0 |
muscle | 19% | 0.23 | 152 / 803 | 0% | 0 | 0 / 0 |
breast | 18% | 0.23 | 81 / 459 | 0% | 0 | 0 / 1118 |
thymus | 16% | 0.20 | 104 / 653 | 0% | 0 | 0 / 605 |
uterus | 16% | 0.19 | 27 / 170 | 0% | 0 | 0 / 459 |
bladder | 14% | 0.19 | 3 / 21 | 0% | 0 | 0 / 504 |
adrenal gland | 14% | 0.17 | 35 / 258 | 0% | 0 | 0 / 230 |
esophagus | 13% | 0.16 | 189 / 1445 | 0% | 0 | 0 / 183 |
stomach | 12% | 0.14 | 44 / 359 | 0% | 0 | 0 / 286 |
skin | 11% | 0.13 | 199 / 1809 | 0% | 0 | 0 / 472 |
lung | 10% | 0.13 | 58 / 578 | 0% | 0 | 0 / 1155 |
blood vessel | 10% | 0.12 | 132 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 8% | 0.09 | 27 / 328 | 0% | 0 | 0 / 178 |
adipose | 7% | 0.08 | 82 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 0.07 | 55 / 929 | 0% | 0 | 0 / 0 |
heart | 6% | 0.07 | 48 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0042554 | Biological process | superoxide anion generation |
GO_0060263 | Biological process | regulation of respiratory burst |
GO_0010310 | Biological process | regulation of hydrogen peroxide metabolic process |
GO_0043020 | Cellular component | NADPH oxidase complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0019899 | Molecular function | enzyme binding |
GO_0016176 | Molecular function | superoxide-generating NADPH oxidase activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | NOXO1 |
Protein name | NADPH oxidase organizer 1 NADPH oxidase organizer 1 (NADPH oxidase regulatory protein) (Nox organizer 1) (Nox-organizing protein 1) (SH3 and PX domain-containing protein 5) |
Synonyms | P41NOX SH3PXD5 |
Description | FUNCTION: Constitutively potentiates the superoxide-generating activity of NOX1 and NOX3 and is required for the biogenesis of otoconia/otolith, which are crystalline structures of the inner ear involved in the perception of gravity. Isoform 3 is more potent than isoform 1 in activating NOX3. Together with NOXA1, may also substitute to NCF1/p47phox and NCF2/p67phox in supporting the phagocyte NOX2/gp91phox superoxide-generating activity. . |
Accessions | ENST00000709273.1 [Q8NFA2-1] ENST00000566005.5 [Q8NFA2-2] ENST00000397280.8 [Q8NFA2-1] ENST00000567471.1 ENST00000354249.8 [Q8NFA2-4] ENST00000709274.1 [Q8NFA2-2] ENST00000709272.1 [Q8NFA2-4] ENST00000709271.1 [Q8NFA2-3] Q8NFA2 ENST00000356120.9 [Q8NFA2-3] H3BN18 |